Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn MoreConnecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MOREEmpowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn moreWorking across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MOREDelivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreClinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn MoreHarness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MOREPharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MOREPrimary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORETrusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MOREOptimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MOREA single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MOREConnected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsFor anyone who has waited in a doctor’s office, being told that the doctor is ready to see you is an all-too-familiar line. Only this time, the setting is virtual, and company sales reps are not immune to this new practice. Due to COVID-19 restrictions in the past year, company sales reps have had limited face-to-face engagements with Healthcare Professionals (HCPs) and shifted to a more digital approach.
Last year, we drew insights from WellTrack 1 to understand how HCP engagement in Southeast Asia (SEA) was “Same, same but different” (Read here). The latest findings from our Southeast Asia WellTrack 2 study in 2021 has revealed that HCPs want a hybrid form of engagement from healthcare companies as in-person and virtual engagement preferences remain equal.
However, a return to pre-pandemic behaviour with preference for more face-to-face interaction could still be possible. HCPs identified key conditions for them to feel comfortable and safe in engaging with company sales reps in a face-to-face capacity, such as when the COVID-19 vaccine is readily available and FDA-approved and when the COVID-19 trend dies down worldwide and in Southeast Asia.
However, as the pandemic continues to impact the region, virtual engagement with companies is here to stay – at least for the foreseeable future. Given the different modes of online engagement, it is important to understand how HCPs prefer to be engaged virtually. WellTrack offers the latest insights on the types of digital engagements that resonate with them the most:
The pandemic has been a strong inflection point for healthcare companies to re-think the way they engage HCPs. Similarly, engaging pharmacists has also changed, though SEA pharmacists still hold a traditional engagement mindset, click here to learn more about SEA pharmacist engagement. Identifying HCP digital preferences is just the start. WellTrack also investigates the right kind of content and topic for each mode of engagement as well as understanding unmet HCP needs and challenges to provide a more holistic view of this digital journey.
For more information on WellTrack data insights across markets, categories and stakeholders, please feel free to contact us or click here for more WellTrack thoughts and perspectives.
Creating an informed effective HCP engagement strategy is the first step, but it raises the time old question “Is what we’re doing working?” Click here to read about KPI strategy and building to improve.
References
1IQVIA WellTrack Wave 2 Southeast Asia (May 2021)